Medications for Chronic Obstructive Airway Disease

18 results
  • advair diskus - fluticasone propionate and salmeterol powder

    (Fluticasone Propionate And Salmeterol)
    Glaxosmithkline Llc
    Advair Diskus treats asthma (patients 4+) and COPD, including chronic bronchitis and emphysema. It reduces COPD exacerbations. Not for acute bronchospasm relief.
  • anoro ellipta - umeclidinium bromide and vilanterol trifenatate powder

    (Umeclidinium Bromide And Vilanterol Trifenatate)
    Glaxosmithkline Llc
    Anoro Ellipta is a maintenance treatment for chronic obstructive pulmonary disease (COPD) in adults. It is not for relief of acute bronchospasm or for treating asthma.
  • bevespi aerosphere - glycopyrrolate and formoterol fumarate aerosol, metered

    (Glycopyrrolate And Formoterol Fumarate)
    Astrazeneca Pharmaceuticals Lp
    Bevespi Aerosphere is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is not for relief of acute bronchospasm or for treating asthma.
  • breo ellipta - fluticasone furoate and vilanterol trifenatate powder

    (Fluticasone Furoate And Vilanterol Trifenatate)
    Glaxosmithkline Llc
    Breo Ellipta is used for maintenance treatment of COPD and asthma in patients aged 5 and older. It is not for relief of acute bronchospasm.
  • breyna - budesonide and formoterol fumarate aerosol, metered

    (Budesonide And Formoterol Fumarate)
    Mylan Pharmaceuticals Inc.
    Breyna (corticosteroid/LABA combination) treats asthma in patients 6 years and older not adequately controlled on an inhaled corticosteroid alone. Also indicated for maintenance treatment of airflow obstruction and reducing exacerbations in COPD, including chronic bronchitis and emphysema. Not for relief of acute bronchospasm.
  • daliresp - roflumilast tablet

    (Roflumilast)
    Astrazeneca Pharmaceuticals Lp
    DALIRESP reduces the risk of COPD exacerbations in adults with severe COPD associated with chronic bronchitis and a history of exacerbations. It is not a bronchodilator and is not for acute bronchospasm relief.
  • dupixent - dupilumab injection, solution

    (Dupilumab)
    Sanofi-Aventis U.S. Llc
    DUPIXENT treats moderate-to-severe atopic dermatitis (6 months+), asthma (6 years+), chronic rhinosinusitis with nasal polyps (12 years+), eosinophilic esophagitis (1 year+), prurigo nodularis, COPD, chronic spontaneous urticaria (12 years+), bullous pemphigoid, and allergic fungal rhinosinusitis in eligible adult and pediatric patients.